The local medical landscape is buzzing with the introduction of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist showing significant results in scientific trials for addressing obesity. https://hypebookmarking.com/story21545968/the-new-retatrutide-australia-a-new-hope-for-weight-loss